Magnetic Resonance Imaging Evaluation of Inner Ear Pathology Using Intra-Tympanic Contrast Agent

Completed · Not applicable

Conditions studied: Meniere's Disease

In brief

This is a pilot study of patients with clinical symptoms of Ménière's disease using injection of diluted magnetic resonance imaging (MRI) contrast agent into the ear to evaluate inner ear structures. The goal is to reproduce imaging findings described by non-United States (US) institutions, improve on image quality with decreased scan time and evaluate the dynamics of the contrast movement into the inner ear structures.

Key facts

Study ID

NCT02080312

Run by

University of California, San Diego

People needed

6

Starts

2012-01-01

Expected to finish

2013-12-01

Last updated by the study team

2016-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Symptoms and clinical exam consistent with Ménière's disease
• Ability to undergo MR exam
• Interest in participating in this study
• Ability to provide informed consent

You may not qualify if…

• Children (under age 18),
• Contraindication to MR imaging (see attached UCSD MR Screening Form)
• Claustrophobia precluding MR exam without sedation
• Contraindication to receiving intravenous gadolinium-based contrast agent (see attached UCSD Contrast Policy)
• Patients who are pregnant or breast feeding (intravenous contrast agents are Category C)
• Contraindication to osmotic challenge (congestive heart failure, renal failure, hepatic failure)

Where it is running

• UC San Diego Health System — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.